bupranolol has been researched along with Chronic Illness in 4 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily, bupranolol, 50 mg once daily, and their combination on exercise-induced ST-segment depression at comparable work load, maximal work load, exercise capacity, frequency of anginal episodes and sublingual nitroglycerin consumption were studied in 30 patients with chronic stable angina pectoris." | 9.07 | Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris. ( Krepp, HP, 1991) |
| "2% solutions of bupranolol on intraocular pressure were investigated in 21 and respectively 20 eyes with chronic uncomplicated open-angle glaucoma." | 7.66 | [Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)]. ( Oancea, I; Trif, V, 1979) |
| "The effects of slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily, bupranolol, 50 mg once daily, and their combination on exercise-induced ST-segment depression at comparable work load, maximal work load, exercise capacity, frequency of anginal episodes and sublingual nitroglycerin consumption were studied in 30 patients with chronic stable angina pectoris." | 5.07 | Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris. ( Krepp, HP, 1991) |
| "2% solutions of bupranolol on intraocular pressure were investigated in 21 and respectively 20 eyes with chronic uncomplicated open-angle glaucoma." | 3.66 | [Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)]. ( Oancea, I; Trif, V, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchegger, G | 1 |
| Vankov, T | 1 |
| Oancea, I | 2 |
| Trif, V | 1 |
| Krepp, HP | 1 |
2 trials available for bupranolol and Chronic Illness
| Article | Year |
|---|---|
[Effect of bupranolol in combination with isosorbide dinitrate in bronchial diseases].
Topics: Bronchial Diseases; Bupranolol; Chronic Disease; Drug Combinations; Humans; Isosorbide Dinitrate; Pr | 1982 |
Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Bupranolol; Chronic Disease; Delayed-Action Preparations; Double-Blind Method | 1991 |
2 other studies available for bupranolol and Chronic Illness
| Article | Year |
|---|---|
[The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bupranolol; Chronic Disease; Drug Combinations; Drug Evalu | 1975 |
[Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)].
Topics: Aged; Bupranolol; Chronic Disease; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intra | 1979 |